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Surgical revascularization, either by means of a
direct bypass graft from the ascending aorta or by
extra-anatomic means, has been the treatment of
choice for occlusive lesions involving the aortic arch
branches. Although lesions of the subclavian and
innominate vessels can be treated with percutaneous
transluminal angioplasty (PTA) with a high degree
of technical success, patency rates range from 43% to
100% at variable follow-up times.1-7 The results of
endovascular treatment of the subclavian, innomi-
nate, and common carotid arteries with angioplasty
and intravascular stenting were examined, and these
results were compared with alternative therapies.
PATIENTS AND METHODS
From January 1993 to August 1997, 87 occlusive
lesions of the innominate, left common carotid, and
subclavian arteries were treated with angioplasty and
intravascular stent placement in 83 patients (41 men
[49.4%] and 42 women [50.6%]; mean age at inter-
vention, 63 years [range, 40 to 85 years]). Informed
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By means of life-table analysis, 84% of the subclavian and innominate interventions,
including initial failures, remain patent by objective means at 35 months. No patients
have required reintervention or surgical conversion for recurrence of symptoms. Of the
11 patients available for follow-up study who underwent common carotid interventions,
10 remain stroke-free at a mean of 14.3 months.
Conclusion: Angioplasty and primary stenting of the subclavian and innominate arteries
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degree of technical success, but should be approached with caution when performed in
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consent about the investigational nature of angioplas-
ty and stent placement in the treatment of lesions
involving the brachiocephalic vessels was obtained
from all patients, as required by our Institutional
Review Board. All the 73 subclavian and innominate
procedures were performed in an angiography suite
under local anesthesia and conscious sedation. Most
(13 of 14, 92.9%) procedures on the common carotid
artery were performed in the operating room via a
cervical incision and direct exposure of the common
carotid above the lesion. After diagnostic arteriogra-
phy, the target lesion was crossed with a standard
0.035-inch guidewire; patients were systemically anti-
coagulated with heparin, and the lesions were treated
by means of angioplasty and primary stenting. 
All lesions were treated with intravascular stents,
irrespective of the results of balloon angioplasty alone.
All but 1 lesion received a Palmaz stent (Johnson and
Johnson Interventional Systems, Warren, NJ); the
remaining lesion was treated with a self-expanding
Wallstent (Schneider, Minneapolis, Minn). The pro-
cedure was terminated when angiographic success
(brisk flow through the target lesion, no evidence of
thrombosis or dissection, and less than 10% residual
stenosis) and hemodynamic success (transstenotic
pressure gradient less than 5 mm Hg) was achieved.
These criteria are more stringent than those described
for “anatomic success” (defined as residual stenosis of
less than 30%) in the reporting standards for lower
extremity arterial endovascular procedures,8 but
reflect the anatomic and hemodynamic criteria that
we use in clinical practice. Patients were given aspirin,
not heparin or Coumadin, after their procedure, and
most were discharged after an overnight hospital stay. 
Basic data on all patients in whom angioplasty
and primary stenting of the supra-aortic trunks was
attempted were captured in a prospective registry.
Results, therefore, are reported on an intent-to-treat
basis. The preprocedural and postprocedural clinical
records, arteriograms, and noninvasive vascular stud-
ies (duplex ultrasound and upper extremity blood
pressure measurements and resting pulse volume
recordings) were then retrospectively reviewed. For
subclavian and innominate interventions, clinical suc-
cess was defined as complete resolution of presenting
symptoms. Hemodynamic success was defined as
normalization of upper-extremity blood pressure
(compared with the normal contralateral arm) imme-
diately after the procedure and improvement of the
arterial pressure index by at least 0.15 (when com-
pared with the normal contralateral arm). To be con-
sidered a late success, upper-extremity blood pressure
had to remain normal or decrease by less than 0.15
(when compared with the contralateral arm), and the
patient had to remain symptom-free. Because of the
difficulty in visualizing the brachiocephalic vessels
noninvasively, data regarding anatomic patency is not
available. These criteria are consistent with accepted
standards for reporting the results of surgical and
percutaneous therapy for peripheral arterial disease.8
Descriptive data on the patient cohort and arter-
ies treated are listed in Tables I and II. “Pre-CABG
RIMA or LIMA” refer to those subclavian or innom-
inate lesions treated to supply adequate inflow to an
internal mammary artery before a coronary bypass
grafting procedure. Three patients (4.6% of 66 arter-
ies) had earlier subclavian angioplasty procedures that
had failed at a mean of 31 months before their angio-
plasty/stent procedure. Of those subclavian arteries
treated for internal mammary steal, 16 of 27 (59.3%)
had stable angina pectoris, whereas the remainder
(11 of 27, 40.7%) had unstable coronary syndromes,
including 4 with acute myocardial infarction.
Fourteen patients underwent procedures for
treatment of occlusive lesions of the proximal left
common carotid artery. Two had failed brachio-
cephalic bypass grafts, one at 18 months before the
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Table I. Descriptive information on 72 patients
who underwent attempted subclavian (66) and






Earlier CABG 38 (52.8)
Earlier sternotomy 40 (55.6)
Earlier brachiocephalic operation 1 (1.4)
Earlier carotid endarterectomy 11 (15.3)
Indication for intervention
Subclavian arteries
LIMA steal 26 (35.6)
RIMA steal 1 (1.4)
Claudication 15 (20.5)
VBI/subclavian steal 10 (13.7)
Embolization 4 (5.5)
Ax-bifem salvage 3 (4.1)
Pre-CABG LIMA 3 (4.1)
Access for other intervention 2 (2.7)
Blood pressure monitoring 1 (1.4)
Arteriovenous fistula failure 1 (1.4)
Innominate arteries
Claudication 5 (6.8)
Pre-CABG RIMA 1 (1.4)
Amaurosis fugax 1 (1.4)
Total 73 (100)
LIMA, Left internal mammary artery; RIMA, right internal
mammary artery; CABG, coronary artery bypass graft; VBI, ver-
tebral-basilar insufficiency; Ax-bifem, axillo-bifemoral bypass
graft.
index procedure and the other at 71 months before
the index procedure. Of 5 stent procedures per-
formed in conjunction with bifurcation endarterecto-
my, 3 were reoperations (2 endarterectomies, 1 inter-
nal carotid replacement with saphenous vein). Of 14
patients treated, 7 (50%) had relative contraindica-
tions to standard surgical bypass grafting or repair of
their common carotid lesions, including severe car-
diomyopathy precluding operation (2), occlusive
lesions of the other brachiocephalic vessels (3), failed
earlier extra-anatomic bypass graft (2), and severe cal-
cification of the ascending aorta precluding coronary
bypass grafting and direct brachiocephalic bypass
grafting (1). Three patients underwent interventional
treatment of multiple brachiocephalic vessels, includ-
ing 1 patient who had all 3 arch vessels repaired and
2 patients in whom the innominate and left common
carotid arteries were treated. All but 2 patients were
treated for atherosclerotic lesions of the brachio-
cephalic vessels; 1 patient had giant cell arteritis, and
Takayasu’s arteritis was diagnosed in the other.
Procedural data are listed in Table III. Most com-
mon carotid interventions were performed via direct
surgical exposure of the common carotid artery in
the operating room, with retrograde passage of a
guidewire through the lesion and subsequent angio-
plasty and stent placement. Because of concern about
creating an iatrogenic dissection with retrograde tra-
versal of tight, eccentric lesions at the common
carotid origin, in 2 patients guidewires were placed
across the lesion (into the external carotid artery) in
an antegrade fashion via the femoral approach. The
guidewire was then retrieved through an arteriotomy
in the common carotid. Finally, the procedure in 1
patient was performed solely from the percutaneous
femoral approach. Of 10 complete subclavian occlu-
sions, 6 were successfully crossed and treated. No
complete occlusions of the innominate or common
carotid arteries were treated. Although most subcla-
vian and innominate lesions were treated from a sin-
gle access site, in 7 patients a combination of femoral
and brachial approaches was required to achieve suc-
cess. This was especially true for complete subclavian
occlusions and for patients whose innominate arter-
ies arose from the aortic arch at an acute angle, mak-
ing deployment of a rigid stent difficult. Most lesions
received stents 15 or 20 mm long (range, 10 to 39
mm). The most common balloon size was either 7 or
8 mm in diameter (range, 5 to 11 mm).
RESULTS
Initial technical success was achieved in 82
(94.3%) of 87 procedures. Sixty-two of 66 subcla-
vian (93.9%), 13 of 14 common carotid (92.9%),
and 7 of 7 innominate interventions (100%) were
initially successful. The inability to cross 4 complete
occlusions of the subclavian artery and the iatro-
genic dissection of a left common carotid artery
lesion accounted for the 5 initial failures. The com-
mon carotid artery dissection was immediately con-
verted to a surgical carotid-subclavian transposition
without complication; there were no untoward
sequelae in the 4 failed subclavian procedures.
Complications occurred in 18 of 87 procedures
(20.7%; Table IV). Half of all access-site complica-
tions required operative repair, and the complica-
tions were most common with the brachial artery
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Table II. Descriptive data on 14 patients who
underwent attempted left common carotid artery





Earlier CABG 3 (21.4)
Earlier sternotomy 3 (21.4)
Earlier brachiocephalic operation 2 (14.3)
Earlier carotid endarterectomy 4 (28.6)
Indication for intervention
TIA from isolated CCA lesion 5 (35.7)
Asymptomatic with tandem ICA stenosis 5 (35.7)
Asymptomatic, isolated CCA 3 (21.4)
TIA, tandem CCA and ICA stenoses 1 (7.1)
Total 14 (100)
CCA, Common carotid artery; ICA, internal carotid artery; TIA,
transient ischemic attack; CABG, coronary artery bypass graft.
Table III. Procedural data for 87 subclavian, com-
mon carotid, and innominate interventions
Characteristic n (%)
Access for intervention—subclavian and
innominate arteries
Femoral only 42 (57.5)
Brachial only 24 (32.9)
Femoral and brachial 7 (9.6)
Total 73 (100)
Access for intervention—common carotid arteries
Retrograde/direct surgical CCA exposure 11 (78.6)
Direct CCA exposure/guidewire via femoral 2 (14.3)
Femoral/percutaneous 1 (7.1)
Mean % stenosis (range, 20 to 100)
Preintervention 81.8
Postintervention 1.1
Mean resting pressure gradient (mm Hg)
Preintervention 54.2
Postintervention 1.9
CCA, common carotid artery.
approach. Embolization to the brachial artery, treat-
ed by embolectomy under local anesthesia, occurred
after successful recanalization of a completely
occluded subclavian artery. Embolization to an
internal mammary graft occurred after treatment of
a subclavian stenosis, resulting in hemodynamic
instability and requiring intra-aortic balloon pump
support. The embolus was successfully treated with
catheter-directed thrombolytic therapy, without
long-term consequence. Early in our experience, 2
stents were inadvertently placed across the origin of
the left vertebral artery during subclavian interven-
tion. One vertebral artery occluded asymptomatical-
ly; the other remains patent through the interstices
of the stent. 
Three iatrogenic dissections occurred during
interventions on the common carotid artery. The
first occurred during an attempt to pass the
guidewire (in a retrograde fashion) across a tight,
eccentric lesion. While attempting to cross the lesion,
the guidewire tracked under the distal extent of the
plaque, near the site of arterial puncture, causing an
iatrogenic dissection several centimeters long.
Despite considerable effort, we were unable to access
the true lumen with the wire. The patient in whom
this occurred required carotid-subclavian transposi-
tion. In 2 patients (after successful passage of a wire
and predilatation of the target lesion), dissections
occurred at the site of the common carotid lesion and
extended into the aortic arch. Both were successfully
treated by placing a stent across the lesion at the ori-
gin of the left common carotid. Finally, 2 patients
(14.3% of 14 common carotid interventions) sus-
tained ipsilateral ischemic strokes after common
carotid stent placement and concomitant ipsilateral
bifurcation endarterectomy. In the first, the stent
remained patent, but the internal carotid occluded
after a reoperative bifurcation endarterectomy and
vein patch angioplasty; this patient died despite
undergoing urgent surgical thrombectomy of the
occluded internal carotid. At the time of emergency
reoperation, the internal carotid was occluded at its
origin with platelet thrombus; antegrade flow was
present in the common and external carotid arteries.
The second patient sustained an embolic episode
(from which he recovered), presumably from a flap at
the proximal end point of a particularly difficult
bifurcation endarterectomy. The 30-day mortality
rate for the entire group was 4.8% (4 of 83 patients)
and was directly related to the endovascular proce-
dure in only 1 instance.
Clinical follow-up is available for 71 (89.9%) of
79 surviving patients, at a mean time of 14.3 months
(range, 1 to 49 months). Objective data (PVR,
upper extremity blood pressure measurement, or
both) is available for 61 of 69 subclavian and innom-
inate lesions, at a mean time of 12.9 months postin-
tervention. Life-table data for the subclavian and
innominate lesions, including initial failures, are pre-
sented in Fig 1. Three patients had objective evi-
dence of subclavian stent failure at a mean of 8
months follow-up; all 3 remain asymptomatic. None
has required reintervention or surgical conversion.
One patient had recurrent embolization to the
upper extremity 29 months after subclavian stent
placement, despite objective evidence of stent paten-
cy. Follow-up data are available for 11 common
carotid interventions. Ten of 11 patients remain
stroke-free, at a mean time of 14.3 months. One
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Table IV. Complications in 87 brachiocephalic
angioplasty and stent procedures
Complication n (%)
Access-site related
Brachial hematoma (no operation required) 3 (3.4)
Brachial arterio-venous fistula (operative repair) 1 (1.1)
Brachial pseudoaneurysm (operative repair) 1 (1.1)
Femoral pseudoaneurysm (operative repair) 1 (1.1)
Embolic, from subclavian to
Brachial artery 1 (1.1)
LIMA 1 (1.1)
Other
Temporary acute renal failure 1 (1.1)
Congest heart failure 1 (1.1)
Non-Q myocardial infarction 1 (1.1)
Technical
Stent covering origin of left vertebral 2 (2.3)
Iatrogenic CCA dissection 3 (3.4)
Stroke (combined CCA stent/CEA) 2 (2.3)
Total 18 (20.7)
LIMA, Left internal mammary artery; CCA, common carotid
artery; CEA, carotid bifurcation endarterectomy.
Fig 1. Life-table patency for 66 subclavian and 7 innom-
inate artery interventions, including initial failures.
patient had an ipsilateral stroke 20 months after his
procedure despite an angiographically normal com-
mon carotid artery, presumably from an ulcerated,
moderately stenotic atheroma at the carotid bifurca-
tion found by means of angiography shortly after the
event. Follow-up data for the common carotid
artery interventions are not presented in life-table
form because of the difficulty in objectively assessing
the success of this intervention noninvasively.
DISCUSSION
Vascular insufficiency of the upper extremities and
cerebral vascular bed was first described in 1944 by
Martorell and Fabre.9 The first report of surgical
treatment of these lesions was published in 1951 by
Shimizu and Sano; they treated 2 common carotid
occlusions, 1 by retrograde thrombectomy, the other
by venous replacement.10 This was followed by
transthoracic innominate endarterectomy by Davis et
al11 in 1956, and prosthetic bypass grafting of the
great vessels by DeBakey et al12 in 1958. Although
the functional results of these procedures were satis-
factory, the operative mortality rate was exceedingly
high.13 Because of concern regarding the risk of
transthoracic procedures, extra-anatomic (carotid-
subclavian) bypass grafting was introduced by
Diethrich et al14 in 1967. Their good results and low
mortality rate were confirmed in a report by Crawford
et al 2 years later; they reduced the mortality rate from
22% with transthoracic repair to 5.6% with carotid-
subclavian bypass grafting.15 Carotid-subclavian
bypass grafting became the treatment of choice for
most lesions involving the brachiocephalic vessels,
especially those involving the proximal subclavian and
common carotid arteries. Although perioperative care
has improved with the results of transthoracic proce-
dures, mortality rates from 5.6% to 18.7% have been
reported.16-18 Recent studies by Fry et al19 (100%
patency rate at 4 years mean follow-up) and Perler et
al20 (92% and 83% primary patency rates at 5 and 8
years, respectively) have confirmed the safety, efficacy,
and durability of carotid-subclavian bypass grafting.
Percutaneous therapy for occlusive arterial disease
may have several advantages over standard surgical
therapy, including its minimally invasive nature,
avoidance of general anesthesia, greater patient
acceptance, and lower cost-per-unit treatment; in
general, however, these procedures are not as durable
as their surgical alternatives. 
Reported series of patients treated with subclavian
angioplasty indicate initial success rates ranging from
83% to 100% for stenoses, less for complete occlusions.
In follow-up studies, patency rates range from
43% for subclavian occlusions to 100% for stenoses at
variable periods of follow-up; these results are gener-
ally not reported on an intent-to-treat basis, howev-
er.1-6 Becker et al,7 reporting on 423 angioplasty
procedures on the innominate and subclavian arteries
compiled from more than 10 series, cited a 92% ini-
tial technical success rate and a 19% recurrence rate at
follow-up periods ranging from 1 to 5 years.
Intravascular stents have been advocated to
improve on the results of balloon angioplasty by pre-
venting elastic recoil, by “tacking” down the dissec-
tion created during angioplasty (which can be a nidus
for thrombus), and perhaps allowing treatment of
complex lesions not amenable to simple angioplasty.
Several small series have documented satisfactory
results with angioplasty and primary stenting for sub-
clavian artery lesions, with initial technical success
rates of 92% to 100% in selected patients and 85% to
100% patency rates at a mean follow-up of 27
months, excluding initial failures.21-24 These results
are similar to those reported in this series, with 94%
initial technical success overall (95% of 73 subclavian
and innominate lesions), and an 84% patency rate at
35 months by means of life-table analysis, including
initial failures. When complete occlusions of the sub-
clavian are excluded, initial success was obtained in
99% of the entire group and in 100% of the subcla-
vian and innominate procedures.
The application of published reporting standards8
for lower extremity endovascular procedures to bra-
chiocephalic interventions is problematic, at best. In
fact, there is no reference to brachiocephalic inter-
ventions in this important document. Nonetheless,
we have attempted to adapt these standards to inter-
ventions performed in the innominate, subclavian,
and common carotid arteries. Both clinical and
hemodynamic success must have been maintained at
the last follow-up examination for the intervention to
be deemed patent, consistent with published stan-
dards. Unfortunately, there is no reliable way, short
of angiography, to assess anatomic patency of inter-
ventions performed in these vessels. We have tried a
number of methods, including duplex ultrasound
(there are no accepted criteria for stenosis, and visu-
alization of intrathoracic vessels is difficult), magnet-
ic resonance angiography (the metallic stent “drops
out” and cannot be visualized), and computed tomo-
graphic angiography (definition is insufficient to
make an accurate estimate of stenosis). Thus, in the
absence of published standards for determining the
success of interventions on these specific vessels, we
have used hemodynamic and clinical means to esti-
mate long-term patency to the best of our ability.
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Most subclavian interventions were performed
from the femoral approach. The left subclavian,
because of its direct takeoff from the distal aortic
arch, lends itself to this technique. The innominate
artery, because of its acute angulation from the arch,
is technically easier to treat from the ipsilateral
brachial artery, although access-site complications
are more common when using this approach. Six of
10 complete occlusions of the subclavian were suc-
cessfully treated; surprisingly, only 1 was complicat-
ed by embolization, to the brachial artery. Although
embolization to the vertebral artery is a potential
risk, this specific complication was not observed.
Perhaps retrograde flow in the vertebral artery dur-
ing balloon inflation is protective. The overall low
incidence of major complications and reasonable
durability of subclavian and innominate intervention
make this procedure an attractive initial treatment,
especially for focal stenoses and in patients with
coronary steal. Although only 4 patients were treat-
ed for pre-coronary artery bypass graft of an internal
mammary artery, intervention is appealing in this
group, especially when other sources of conduit for
coronary bypass grafting are unavailable. 
Although the natural history of occlusive lesions
involving the common carotid artery is not well-
defined, they are known to cause cerebral ischemia
from embolization and thrombosis. Berguer et al25
reported their experience with surgical reconstruc-
tion of the supra-aortic trunks, which included 13
patients who were asymptomatic. We would agree
that only high-grade (more than 75% stenosis)
lesions of the common carotid proximal to a patent
internal carotid artery should be considered for
repair in asymptomatic patients. 
Our procedure for angioplasty and stenting of the
common carotid artery is derived from the technique
described by Queral and Criado21 in 1995. As the
cerebrovascular complications of surgical and inter-
ventional treatment of the carotid arteries is princi-
pally related to thromboembolism, we believed that,
by controlling the common carotid distal to the site
of intervention and by “flushing” the vessel before
restoring flow to the internal carotid, we could pre-
vent periprocedural ischemic stroke. Although this
line of reasoning seems sound, the occurrence of 2
strokes in the course of 14 common carotid inter-
ventions is unsettling. Both were related to “com-
bined” procedures (common carotid stenting and
standard bifurcation endarterectomy) and appear to
be related to difficult endarterectomies and not to
the stent procedure itself. However, thrombus aggre-
gating on the stent during brief periods of stagnant
flow (ie, during placement and removal of an intralu-
minal carotid shunt) may have been the ultimate
cause of these complications. We have had success
with 1 common carotid lesion treated percutaneous-
ly from the femoral approach. Perhaps combined
lesions of the common and internal carotid arteries
should be treated separately. Favorable lesions of the
common carotid (nonulcerated, no intraluminal
thrombus) would be treated percutaneously; a tight
stenosis of the ipsilateral internal carotid may be
somewhat protective, in that debris would embolize
preferentially into a patent external carotid. Crossing
tight, eccentric stenoses in an antegrade fashion
would also likely prevent the iatrogenic dissection
seen with the retrograde technique, which occurred
during 1 procedure in this series. The internal carotid
lesion could then be treated by standard surgical
means. Although both lesions may be treated percu-
taneously, we have no experience with this approach.
The results, both initial and late, of various treat-
ment options for atherosclerotic lesions of the supra-
aortic trunks seem to favor surgical therapy, espe-
cially when complete occlusions are included. The
addition of intravascular stents seem to have
improved the results of balloon angioplasty alone,
but prospective, randomized comparisons are not
available. Endovascular treatment of the subclavian
and innominate arteries is an attractive option for
focal stenoses that do not involve the origin of the
vertebral artery, in patients with conditions preclud-
ing standard surgical treatment, and especially in
patients with internal mammary (coronary) steal
syndromes, who may be at higher risk for surgical
repair. These procedures seem to be durable and do
not preclude or complicate subsequent operation.
The efficacy of endovascular repair of common
carotid artery stenoses is less certain. These proce-
dures should certainly be considered in patients
without a good surgical option, but caution is urged
when they are performed in combination with bifur-
cation endarterectomy. The exact mechanism of
stroke in these “combined” procedures is uncertain
at present; the best method and sequence of treat-
ment for tandem stenoses of the common and inter-
nal carotid arteries deserves further investigation.
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